Fariba Rezaee

Dr. Fariba Rezaee

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2014 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
SGSteve N. Georas
Steve N. Georas
Fariba RezaeeFariba Rezaee
Fariba Rezaee

23 March 2022 in European Respiratory Review
Verified
Journal Article
Open access
PDF file
MAMahyar Aghapour
Mahyar Aghapour
NUNiki Ubags
Niki Ubags
DBDunja Bruder
Dunja Bruder
PHPieter Hiemstra
Pieter Hiemstra
VSVenkataramana Sidhaye
Venkataramana Sidhaye
Irene HeijinkIrene Heijink
Irene Heijink
Chronic exposure to environmental pollutants is a major contributor to the development and progression of obstructive airway diseases, including asthma and COPD. Understanding the mechanisms underlying the development of obstructive lung diseases upon exposure to inhaled pollutants will lead to novel insights into the pathogenesis, prevention and treatment of these diseases. The respiratory epithelial lining forms a robust physicochemical barrier protecting the body from inhaled toxic particles and pathogens. Inhalation of airborne particles and gases may impair airway epithelial barrier function and subsequently lead to exaggerated inflammatory responses and airway remodelling, which are key features of asthma and COPD. In addition, air pollutant-induced airway epithelial barrier dysfunction may increase susceptibility to respiratory infections, thereby increasing the risk of exacerbations and thus triggering further inflammation. In this review, we discuss the molecular and immunological mechanisms involved in physical barrier disruption induced by major airborne pollutants and outline their implications in the pathogenesis of asthma and COPD. We further discuss the link between these pollutants and changes in the lung microbiome as a potential factor for aggravating airway diseases. Understanding these mechanisms may lead to identification of novel targets for therapeutic intervention to restore airway epithelial integrity in asthma and COPD.

1 April 2013 in Tissue Barriers
Verified
Journal Article
Open access
BSBahman Saatian
Bahman Saatian
Fariba RezaeeFariba Rezaee
Fariba Rezaee
SDSamantha Desando
Samantha Desando
JEJason Emo
Jason Emo
TCTim Chapman
Tim Chapman
SGSteve N. Georas
Steve N. Georas
Emerging evidence indicates that airway epithelial barrier function is compromised in asthma, a disease characterized by Th2-skewed immune response against inhaled allergens, but the mechanisms inv...

1 December 2018 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
MRMohammed T. Rahman
Mohammed T. Rahman
Chaitali GhoshChaitali Ghosh
Chaitali Ghosh
MHMohammed Hossain
Mohammed Hossain
DLDebra Linfield
Debra Linfield
Fariba RezaeeFariba Rezaee
Fariba Rezaee
ABAnette H.H. van Boxel-Dezaire
Anette H.H. van Boxel-Dezaire

1 May 2014 in American Journal of Respiratory Cell and Molecular Biology
Verified
Journal Article
Closed access
Fariba RezaeeFariba Rezaee
Fariba Rezaee
SGSteve N. Georas
Steve N. Georas
Epithelial permeability is a hallmark of mucosal inflammation, but the molecular mechanisms involved remain poorly understood. A key component of the epithelial barrier is the apical junctional complex that forms between neighboring cells. Apical junctional complexes are made of tight junctions and adherens junctions and link to the cellular cytoskeleton via numerous adaptor proteins. Although the existence of tight and adherens junctions between epithelial cells has long been recognized, in recent years there have been significant advances in our understanding of the molecular regulation of junctional complex assembly and disassembly. Here we review the current thinking about the structure and function of the apical junctional complex in airway epithelial cells, emphasizing the translational aspects of relevance to cystic fibrosis and asthma. Most work to date has been conducted using cell culture models, but technical advancements in imaging techniques suggest that we are on the verge of important new breakthroughs in this area in physiological models of airway diseases.

1 December 2011 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
Fariba RezaeeFariba Rezaee
Fariba Rezaee
NMNida Meednu
Nida Meednu
JEJason A. Emo
Jason A. Emo
BSBahman Saatian
Bahman Saatian
TCTimothy J. Chapman
Timothy J. Chapman
SGSteve N. Georas
Steve N. Georas